Want to see ENSG full AI Analyst Report?
ENSG Stock Chart & Stats
$172.99
$4.74(2.74%)
At close: 4:00 PM EDT
$172.99
$4.74(2.74%)
Day’s Range― - ―
52-Week Range$141.58 - $218.00
Previous CloseN/A
Volume433.07K
Average Volume (3M)891.21K
Market Cap
$10.11B
Enterprise Value$13.66K
Total Cash (Recent Filing)$320.84M
Total Debt (Recent Filing)$2.25B
Price to Earnings (P/E)27.3
Beta0.13
Next Earnings
Feb 10, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.14%
Share Statistics
EPS (TTM)6.57
Shares Outstanding58,445,400
10 Day Avg. Volume454,074
30 Day Avg. Volume891,208
Financial Highlights & Ratios
PEG Ratio2.06
Price to Book (P/B)4.47
Price to Sales (P/S)1.97
P/FCF Ratio26.93
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$221.00Price Target Upside27.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)7.56
Revenue Forecast (FY)$5.84B
Bulls Say, Bears Say
Bulls Say
Revenue & Free Cash Flow GrowthEnsign has produced durable topline expansion from 2021–2025 with TTM revenue above 2025 and consistently positive free cash flow. Sustained cash generation supports reinvestment, M&A, buybacks and working capital needs, reducing reliance on external financing over the medium term.
High Clinical Quality And Record OccupancyRecord occupancy and strong quality ratings are structural advantages: higher occupancy and better clinical outcomes drive referral flows, favorable payor relationships and pricing power over time. Superior quality reduces regulatory friction and supports stable utilization across business cycles.
Ample Liquidity And Active, Disciplined M&AMaterial available liquidity and modest leverage enable continued bolt-on acquisitions and portfolio optimization. The combination of >$1B dry powder and ongoing accretive deal flow supports scalable revenue growth and market share gains while preserving financial flexibility.
Bears Say
Leverage Volatility And 2025 Debt SpikeYear-to-year swings in leverage, including a pronounced 2025 spike, indicate financing strategy variability. Persistent volatility in debt levels can raise refinancing and covenant risk, constrain capital allocation in downturns, and reduce resilience to reimbursement or operating shocks.
Gross Margin Compression / Cost PressureCompression of gross margins versus prior years suggests sustained cost pressure (labor, supplies, operations) or pricing/tmix challenges. If persistent, margin pressure erodes operating leverage from scale and limits the company’s ability to absorb reimbursement cuts or fund margin-accretive investments.
Payer And Reimbursement Risk From Managed Care/MedicaidHeavy reliance on Medicare/Medicaid and managed-care contracts creates structural exposure to reimbursement policy, claim reviews and state budget cycles. Elevated review intensity or Medicaid funding pressure can reduce revenue visibility and increase collections risk over the medium term.
The Ensign Group News
ENSG FAQ
What was The Ensign’s price range in the past 12 months?
The Ensign lowest stock price was $141.58 and its highest was $218.00 in the past 12 months.
What is The Ensign’s market cap?
The Ensign’s market cap is $10.11B.
When is The Ensign’s upcoming earnings report date?
The Ensign’s upcoming earnings report date is Feb 10, 2027 which is in 196 days.
How were The Ensign’s earnings last quarter?
The Ensign released its earnings results on Jul 27, 2026. The company reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.848 by $0.072.
Is The Ensign overvalued?
According to Wall Street analysts The Ensign’s price is currently Undervalued.
Does The Ensign pay dividends?
The Ensign pays a Quarterly dividend of $0.065 which represents an annual dividend yield of 0.14%. See more information on The Ensign dividends here
What is The Ensign’s EPS estimate?
The Ensign’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does The Ensign have?
The Ensign has 58,445,400 shares outstanding.
What happened to The Ensign’s price movement after its last earnings report?
The Ensign reported an EPS of $1.92 in its last earnings report, beating expectations of $1.848. Following the earnings report the stock price went up 2.937%.
Which hedge fund is a major shareholder of The Ensign?
Currently, no hedge funds are holding shares in ENSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
The Ensign Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$221.00 (27.75% Upside)
$221.00 (27.75% Upside)
Blogger Sentiment
Bullish
ENSG Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 257.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.1%
Last 30 Days ▲ 6.9%
Last 30 Days ▲ 6.9%
News Sentiment
Very Bullish
Bullish news 83%
Bearish news 17%
Bearish news 17%
Technicals
SMA
Negative
20 days / 200 days
Momentum
25.74%
12-Months-Change
Fundamentals
Return on Equity
0.14%
Trailing 12-Months
Asset Growth
16.61%
Trailing 12-Months
Company Description
The Ensign
The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such as physical, occupational, and speech therapy, among other specialized healthcare provisions. Beyond direct medical care, the company furnishes essential amenities like lodging, customized dietary programs, and opportunities for social engagement, recreation, and entertainment. Ensign additionally manages senior living facilities and delivers convenient mobile diagnostic services. Its diverse array of supplementary services includes digital X-rays, ultrasounds, electrocardiograms, laboratory analyses, sub-acute care, and patient transportation, which can be provided either in patients' residences or at long-term care facilities. The company also engages in the leasing of real estate properties. As of April 4, 2022, Ensign operated a network of 252 healthcare facilities spread across thirteen U.S. states: Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The Ensign Group, Inc. was established in 1999 and is headquartered in San Juan Capistrano, California.
ENSG Company Deck
ENSG Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed multiple strong operational and financial positives: record occupancy, meaningful year-over-year revenue and EPS growth, raised guidance, disciplined balance sheet with ample liquidity, accelerating M&A and strong clinical outcomes across the portfolio. Lowlights were largely forward-looking risks and transitional items (ERP implementation, short-term EPS drag from turnaround deals, seasonality and potential state budget uncertainty) rather than current performance shortfalls. Overall the positive items materially outweigh the manageable and disclosed risks.View all ENSG earnings summariesENSG Stock 12 Month Forecast
Average Price Target
$221.00
▲(27.75% Upside)
Technical Analysis
Encompass Health
―
National Healthcare
―
Tenet Healthcare
―
Universal Health
―
Surgery Partners
―
Ownership Overview
1.56% Insiders
33.64% Mutual Funds
4.92% Other Institutional Investors
39.58% Public Companies and
Individual Investors